S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
MarketsFN
Home/Hedge Funds/Darwin Global Management/Q2 2026

Darwin Global Management

Period: Q2 2026 · Filed: 2026-08-14
View on SEC EDGAR
AUM
$3.76B
Total portfolio value
Positions
5
Reported securities
Top Holding
RVMD
54.5% $2.05B
QoQ Changes
+0 / -1
new · exited
⚠️13F Filing Disclosure

AUM figures shown are calculated by summing the reported market value of all positions in SEC 13F-HR filings — not the fund's actual assets under management.

  • Excludes cash, bonds, private equity, short positions, and foreign-listed stocks not required to be reported.
  • For PUT and CALL options, the reported Value is the notional value of the underlying shares — not the option premium paid. This significantly overstates the actual capital at risk.
  • Actual fund AUM is typically higher and includes strategies, instruments, and positions that never appear in a 13F.
  • 13F filings cover institutional managers with ≥$100M in 13F securities. Positions reflect end-of-quarter holdings, disclosed up to 45 days after the period ends.

Data sourced from SEC EDGAR. This tracker is for informational purposes only and does not constitute investment advice.

Portfolio Holdings

Top 5 positions

⚠️ Performance % calculated from filing date ( 2026-08-14) shown is the underlying stock price movement — not the derivative's P&L.
TickerIssuerNotionalPort %@ FilingNow (EOD)Since FilingAllocation
RVMDREVOLUTION MEDICINES INC$2.05B54.45%$187.28$203.71+8.8%
54.5%
INSMINSMED INC$673.6M17.91%$106.62$123.74+16.1%
17.9%
BLTEBELITE BIO INC$456.6M12.14%$153.99$162.80+5.7%
12.1%
ABVXABIVAX SA$348.2M9.26%$133.26$118.96-10.7%
9.3%
ROIVROIVANT SCIENCES LTD$234.3M6.23%$35.39$36.20+2.3%
6.2%

Quarter-on-Quarter Activity

Q2 2026 vs. Q1 2026

New Positions

None this quarter

Exited Positions (1)

TickerIssuerNotional
DNTHDIANTHUS THERAPEUTICS INC$1.5M

Increased (3)

TickerIssuerNotionalShares ΔSince Filing
RVMDREVOLUTION MEDICINES INC$1.84B+380.8%+8.8%
ABVXABIVAX SA$-3.9M+4.4%-10.7%
BLTEBELITE BIO INC$0.5M+0.6%+5.7%

Trimmed (2)

TickerIssuerNotionalShares ΔSince Filing
INSMINSMED INC$-1903.0M-61.7%+16.1%
ROIVROIVANT SCIENCES LTD$54.8M-0.7%+2.3%
Back to Hedge Funds